These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Losordo DW; Vale PR; Symes JF; Dunnington CH; Esakof DD; Maysky M; Ashare AB; Lathi K; Isner JM Circulation; 1998 Dec 22-29; 98(25):2800-4. PubMed ID: 9860779 [TBL] [Abstract][Full Text] [Related]
27. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Su H; Lu R; Kan YW Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13801-6. PubMed ID: 11095751 [TBL] [Abstract][Full Text] [Related]
29. Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy. Results in normal and ischemic porcine models. Kornowski R; Leon MB; Fuchs S; Vodovotz Y; Flynn MA; Gordon DA; Pierre A; Kovesdi I; Keiser JA; Epstein SE J Am Coll Cardiol; 2000 Mar; 35(4):1031-9. PubMed ID: 10732905 [TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer. Lee M; Rentz J; Bikram M; Han S; Bull DA; Kim SW Gene Ther; 2003 Sep; 10(18):1535-42. PubMed ID: 12907944 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases. Aoki M; Morishita R; Taniyama Y; Kaneda Y; Ogihara T J Atheroscler Thromb; 2000; 7(2):71-6. PubMed ID: 11426585 [TBL] [Abstract][Full Text] [Related]
33. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization. Sayeed-Shah U; Mann MJ; Martin J; Grachev S; Reimold S; Laurence R; Dzau V; Cohn LH J Thorac Cardiovasc Surg; 1998 Nov; 116(5):763-9. PubMed ID: 9806383 [TBL] [Abstract][Full Text] [Related]
34. [Therapeutic angiogenesis awakens hope. New blood vessels for arterial occlusive disease patients? (interview by Dr. Judith Neumaier)]. Diehm C MMW Fortschr Med; 2002 Jul; 144(27-28):14. PubMed ID: 12198872 [No Abstract] [Full Text] [Related]
35. One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients. Fortuin FD; Vale P; Losordo DW; Symes J; DeLaria GA; Tyner JJ; Schaer GL; March R; Snell RJ; Henry TD; Van Camp J; Lopez JJ; Richenbacher W; Isner JM; Schatz RA Am J Cardiol; 2003 Aug; 92(4):436-9. PubMed ID: 12914874 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Epstein SE; Fuchs S; Zhou YF; Baffour R; Kornowski R Cardiovasc Res; 2001 Feb; 49(3):532-42. PubMed ID: 11166266 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic angiogenesis: the present and the future. Ferreira AC Arq Bras Cardiol; 2002 Feb; 78(2):145-7. PubMed ID: 11887188 [No Abstract] [Full Text] [Related]
38. Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review. Kusumanto YH; Hospers GA; Mulder NH; Tio RA Int J Cardiovasc Intervent; 2003; 5(1):27-34. PubMed ID: 12623562 [TBL] [Abstract][Full Text] [Related]
39. Stimulation of peripheral angiogenesis by vascular endothelial growth factor (VEGF). Baumgartner I; Isner JM Vasa; 1998 Nov; 27(4):201-6. PubMed ID: 9859738 [TBL] [Abstract][Full Text] [Related]
40. Gene therapy in the cardiovascular system: an update. Sinnaeve P; Varenne O; Collen D; Janssens S Cardiovasc Res; 1999 Dec; 44(3):498-506. PubMed ID: 10690281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]